Compare · MDLN vs SINT
MDLN vs SINT
Side-by-side comparison of Medline Inc. (MDLN) and SiNtx Technologies Inc. (SINT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SINT operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 3593.9x SINT ($13.4M).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 3 for SINT).
- MDLN has more recent analyst coverage (25 ratings vs 1 for SINT).
- Company
- Medline Inc.
- SiNtx Technologies Inc.
- Price
- -
- -
- Market cap
- $48.08B
- $13.4M
- 1M return
- +11.97%
- -
- 1Y return
- -11.77%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2014
- News (4w)
- 7
- 3
- Recent ratings
- 25
- 1
SiNtx Technologies Inc.
Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products. It has a collaboration agreement with Oxford Performance Materials, Inc. to develop a poly-ether-ketone-ketone silicon nitride composite based on OXPEKK SC solution casting technology. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest SINT
- SEC Form 8-K filed by SiNtx Technologies Inc.
- SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
- SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
- SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- SEC Form EFFECT filed by SiNtx Technologies Inc.
- SiNtx Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
- SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by SiNtx Technologies Inc.